Brief: Enanta Pharmaceuticals Announces Closing Of Upsized Public Offering Of Common Stock
02/10/2025 21:19
Oct 2 (Reuters) - Enanta Pharmaceuticals Inc ENTA.O: ENANTA PHARMACEUTICALS ANNOUNCES CLOSING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK, INCLUDING FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES Source text: ID:nBw19qjQ1a Further company coverage: ENTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates